Screener / SEC EDGAR /CIK 0001600033 /10-K filed May 21, 2026, compared with May 29, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer staples · Cosmetics

e.l.f. Beauty, Inc. ELF

Compare with peers Embed
The 10-K against last year's

135 changes: 17 added, 10 removed, 107 reworded, 1 quiet changes

10-K May 21, 2026 vs May 29, 2025

10-K 0001600033-26-000020 (May 21, 2026) vs 10-K 0001600033-25-000016 (May 29, 2025) Not compared: Accounting Policies.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

276 paragraphs · 8 new · 89 reworded · 2 gone · 10-K May 21, 2026 against May 29, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 272 · 50% changed Every version of it
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates. We intend to file one or more registration statements on Form S-8 to cover additional shares of our common stock or securities convertible into or exchangeable for shares of our common stock pursuant to automatic increases in the number of shares reserved under our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan. Accordingly, shares registered under these registration statements on Form S-8 will be available for sale in the open market.
Paragraph 181 · 48% changed Every version of it
Additional state We have registered our cosmetic product facilities and federal requirements may be imposed on consumer listed our cosmetic products as well as cosmetics, cosmetic ingredients, or with the labeling and packaging of products intended FDA. In addition, the FDA was required under MoCRA to propose mandatory GMPs for use as cosmetics. For example, on cosmetics by December 29, 2022, Congress enacted the MoCRA. MoCRA created new compliance requirements for manufacturers of cosmetic products in the United States 2024 and also significantly expanded the FDA's authority to oversee and regulate cosmetics. Under MoCRA, companies must comply with new requirements for cosmetics, finalize such as new labeling requirements for certain products, safety substantiation, facility registration, product listing, adverse event reporting, good manufacturing practice requirements and mandatory recalls. In addition, MoCRA provided FDA with new enforcement authorities over cosmetics, such as the ability to initiate mandatory recalls and to obtain access certain product records. Many of the requirements were originally scheduled to become applicable on GMPs by December 29, 2023, with some of the requirements, such as those relating 2025, but these deadlines were delayed and release dates are still to labeling, scheduled to become applicable later in 2024 and 2025; however, on November 8, 2023, the FDA advised that it would not enforce the requirements related to cosmetic product facility registration and cosmetic product listing until July 1, 2024 to provide regulated industry additional time to comply with the requirements. We satisfied the requirements related to cosmetic product facility registration and cosmetic product listing by the July 1, 2024 deadline. be determined. We are unable to ascertain at this time the full impact that complying with MoCRA will have on our business. Compliance with the new requirements may further increase the cost of manufacturing certain of our products and could have a material adverse effect on our business, financial condition and results of operations.
Paragraph 177 · 46% changed Every version of it
There has been an increase in regulatory activity and activism in the United States and abroad, and the regulatory landscape is becoming more complex with increasingly strict requirements. If this trend continues, we may find it necessary to alter some of the ways we have traditionally manufactured and marketed our products in order to stay in compliance with a changing regulatory landscape, and this could add to the costs of our operations and have an adverse impact on our business. To the extent federal, state, local or foreign regulatory changes regarding consumer protection, or the ingredients, claims or safety of our products occur in the future, they could require us to reformulate or discontinue certain of our products, revise the product packaging or labeling, or adjust operations and systems, any of which could result in, among other things, increased costs, delays in product launches, product returns or recalls and lower net sales, and therefore could have a material adverse effect on our business, financial condition and results of operations. Noncompliance with applicable regulations could result in enforcement action by the FDA or other regulatory authorities within or outside the United States, including but not limited to product seizures, injunctions, product recalls and criminal or civil monetary penalties, all of which could have a material adverse effect on our business, financial condition and results of operations.
Paragraph 263 · 45% changed Every version of it
Our amended and restated certificate of incorporation authorizes our board of directors, without the approval of our stockholders, to issue up to 30 million shares of our preferred stock, subject to limitations prescribed by applicable law, rules and regulations and the provisions of our amended and restated certificate of incorporation, as shares of preferred stock in series, to establish from time to time the number of shares to be included in each such series and to fix the designation, powers, preferences and rights of the shares of each such series and the qualifications, limitations or restrictions thereof. The powers, preferences and rights of these additional series of preferred stock may be senior to or on parity with our common stock, which may reduce its value.
Paragraph 58 · 42% changed Every version of it
Starting in July 2018, the US government announced a series of lists covering thousands of categories of Chinese origin products subject to US tariffs in addition to the tariffs that have historically applied to such products. The majority of our products are sourced and manufactured in China and have been subject to a US 25% tariff since May 2019. In March and April Beginning in early 2025, the Trump US administration announced a series of additional tariffs on most products from countries worldwide, including higher tariffs on substantially all products of Chinese origin. Since then, the Trump US administration has increased, reduced or temporarily paused some of the increased tariffs. We cannot predict whether such reductions will remain in place or pauses will be extended or will lapse, whether On February 20, 2026, the Trump US Supreme Court invalidated tariffs previously imposed under the International Emergency Economic Powers Act (“IEEPA”). Following this ruling, the US administration will initiated new tariffs at different rates under alternative legislative powers, which increases the uncertainty around tariffs. The current US administration may continue to increase impose additional tariffs under US trade laws. Although certain tariffs were invalidated, the potential availability, timing, and amount of any refunds associated with the ruling remains highly uncertain. Given the uncertainty regarding the scope and duration of the current and potential tariffs, as well as the potential for additional trade actions by the United States or whether other countries, the Trump administration will enter into agreements with countries specific impact to reduce tariffs our business, results of operations and financial conditions is not certain but could be material.
Paragraph 211 · 42% changed Every version of it
We are, and may in the future become, party to litigation, regulatory proceedings or other disputes. For example, we are currently parties to litigation as described in Note 9 Commitments and Contingencies, in the Notes to Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K. In general, claims made by or against us in disputes and other legal or regulatory proceedings can be expensive and time consuming to bring or defend against, requiring us to expend significant resources and divert the efforts and attention of our management and other personnel from our business operations. These potential claims include, but are not limited to, personal injury claims, class action lawsuits, intellectual property claims, privacy claims, employment litigation and regulatory investigations and causes of action relating to the advertising and promotional claims about our products. Any adverse determination against us in these proceedings, or even the allegations contained in the claims, regardless of whether they are ultimately found to be without merit, may also result in settlements, injunctions or damages that could have a material adverse effect on our business, financial condition and results of operations.
Paragraph 15 · 41% changed Every version of it
The growth of our brands depends largely on our ability to provide a high-quality consumer experience, which in turn depends on our ability to bring innovative products to the market at competitive prices that respond to consumer demands and preferences. Additional factors affecting our consumer experience include our ability to provide appealing store sets in retail stores, the maintenance and stocking of those sets by our retail customers, the overall shopping experience provided by our retail customers, a reliable and user-friendly website interface and mobile applications for our consumers to browse and purchase products on our e-commerce websites and mobile applications. If we are unable to preserve our reputation, enhance our brand recognition or increase positive awareness of our products and in-store and Internet platforms, it may be difficult for us to maintain and grow our consumer base, and our business, financial condition and results of operations may be materially and adversely affected.
Paragraph 164 · 40% changed Every version of it
We sell many of our products to customers located outside the United States. In addition, substantially all of our third-party suppliers and manufacturers are located in China and certain other foreign countries. We intend to continue to sell to customers outside the United States and maintain our relationships in China and other foreign countries where we have suppliers and manufacturers. Further, we recently opened offices in the UK and India and hired new teams of employees to support our international expansion, and we are establishing additional relationships in other countries to grow our operations. The substantial up-front investment required, the lack of consumer awareness of our products in jurisdictions outside of the United States, differences in consumer preferences and trends between the United States and other jurisdictions, the risk of inadequate intellectual property protections and differences in packaging, labeling and related laws, rules and regulations are all substantial matters that need to be evaluated prior to doing business in new territories. We cannot be assured that our international efforts will be successful.

MD&A

78 paragraphs · 9 new · 41 reworded · 8 gone · 10-K May 21, 2026 against May 29, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 8 · 47% changed
Starting in July 2018, the US government announced a series of lists covering thousands of categories of Chinese origin products subject to US tariffs in addition to the tariffs that have historically applied to such products. The majority of our products are sourced and manufactured in China and have been subject to a US 25% tariff since May 2019. Furthermore, in March and April 2025, the Trump administration announced Throughout 2025 we were subject to a series range of additional tariffs tariff rates on products imports from countries worldwide, some of which have been temporarily paused or reduced. China ranging from 25% to as high as 170%.
Paragraph 72 · 45% changed
We evaluate our indefinite-lived intangible asset to determine whether current events and circumstances continue to support an indefinite useful life. In addition, our indefinite-lived intangible asset is tested for impairment annually. The indefinite-lived intangible asset impairment test consists of a comparison of the fair value of each asset with its carrying value, with any excess of carrying value over fair value being recognized as an impairment loss. We are also permitted to make a qualitative assessment of whether it is more likely than not that an indefinite-lived intangible asset’s fair value is less than its carrying value prior to applying the quantitative assessment. If based on our qualitative assessment it is more likely than not that the carrying value of the asset is less than its fair value, then a quantitative assessment may be required.
Paragraph 10 · 44% changed
See the risk factor titled “Additional “Changes in the US tariffs or other and international trade policies, including tariffs, trade restrictions placed on imports, and retaliatory trade measures taken by other countries and resulting trade wars may have a material adverse impact on the Company’s financial condition and results of operations” included as part of Item 1A. Risk Factors of this Annual Report on Form 10-K for additional information regarding risk related to tariffs. our business,
Paragraph 14 · 43% changed
On March 3, August 5, 2025, the Company we entered into the Fourth Fifth Amendment to the Amended and Restated Credit Agreement and First Amendment to Pledge and Security Agreement (the “Fourth “Fifth Amendment”). The Fourth Fifth Amendment, among other things, established a revolving credit term loan facility in an aggregate original principal amount of $500 $600.0 million (the “New Revolving “Term Facility”), refinanced made customary changes in connection with adding a term loan facility, increased the existing indebtedness under the Existing Credit Agreement and reduced maximum permitted consolidated total net leverage ratio financial covenant, increased the interest rate margin for loans. Additionally, certain baskets loans under our existing Revolving Credit Facility and increased the Amended unused line fee under our existing Revolving Credit Agreement were increased as part of the Fourth Amendment. Facility. The proceeds of the New Revolving Term Facility are were made available to e.l.f e.l.f. Cosmetics and certain of our other subsidiaries to pay a portion of the Company consideration for working capital, capital expenditures and other general corporate purposes, including to finance acquisitions and investments permitted under the Amended Credit Agreement and other permitted distributions on account of our equity interests of the Company and its subsidiaries. In addition, up to $35 million of the New Revolving Facility is available for issuing letters of credit. rhode Acquisition. The maturity date of the New Revolving Term Facility is March 3, 2030. The unused balance of the New Revolving Credit Facility as of March 31, 2025 was $243.3 million.
Paragraph 56 · 42% changed
On August 28, 2023, the Company we entered into the Second Amendment to the Amended and Restated Credit Agreement (the “Second Amendment”). Pursuant to the Second Amendment, the Company we borrowed incremental term loans in a an aggregate original principal amount equal to of $115.0 million under the Amended Credit Agreement (the “Incremental Term Loan”). The Incremental Term Loan bore interest at a rate per annum equal to, at the Company’s election, adjusted term SOFR or an alternate base rate as set forth in the Second Amendment, plus an interest rate margin, based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.50% to 2.375%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, and (ii) in the case of alternate base rate loans, 0.50% to 1.375%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. The Incremental Term Loan amortized at 5.00% per annum payable in equal quarterly installments of 1.25% per annum, commencing with the fiscal quarter ended on December 31, 2023. The Company We used the Incremental Term Loan Loan, together with cash from its our balance sheet and additional borrowings under our Amended Revolving Credit Facility Facility, to consummate the Acquisition acquisition of Naturium (as defined in Note 3 hereto) 3, “Acquisitions,” in the Notes to our unaudited condensed consolidated financial statements included elsewhere in this Annual Report on Form 10-K) and to pay related fees and expenses in connection with the Acquisition acquisition of Naturium and Second Amendment.
Paragraph 77 · 34% changed
See Note 2, Summary “Summary of significant accounting policies to policies,” in the Notes to our consolidated financial statements included elsewhere in Part IV, Item 15. “Exhibits, Financial Statement Schedules” this Annual Report on Form 10-K for information regarding new accounting pronouncements.
Paragraph 11 · 34% changed
See the risk factor titled “Additional US tariffs or other restrictions placed on imports, retaliatory trade measures taken by other countries and resulting trade wars may have a material adverse impact on the Company’s financial condition and results of operations” included as part of Item 1A. Risk Factors factors of this Annual Report on Form 10-K for additional information regarding risk related to tariffs.
Paragraph 65 · 31% changed
The interest rate as of March 31, 2025 2026 for the Amended Revolving Credit Agreement Facility was approximately 5.4% 5.4%. The unused balance of the Revolving Credit Facility as of March 31, 2026 was $243.3 million.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Risk Factors269 words changed in this paragraph; it is 58% similar to last year's version.
Many of our products may be considered discretionary items for consumers. Consumer spending on beauty products is influenced by general economic conditions and the availability of discretionary income. Adverse economic conditions in the United States, Canada, the UK, the EU, China or any of the other jurisdictions in which we conduct significant business, such as the current inflationary economic environment, rising interest rates, financial distress caused by recent or potential bank failures and the associated or a banking crisis, an economic recession, depression or downturn, a tightening of the credit markets, high energy prices or higher unemployment levels, may lead to decreased consumer spending, reduced credit availability and a decline in consumer confidence and demand, each of which poses a risk to our business. For example, US and global markets have been experiencing experienced volatility and disruption due to interest rate and inflation increases, such as higher inflation rates in the United States, which increased in the second half of 2021 and have remained above the Federal Reserve’s inflation target, as well as the continued escalation of geopolitical tensions, tensions and conflict, including those as a result of resulting from the conflicts between Russia and Ukraine and war in Iran, the broader conflict in the Middle East. East and Russia's invasion of Ukraine. We have experienced and continue to experience inflationary pressures in certain areas of our business. Although our business has not yet been materially negatively impacted by such inflationary pressures, we cannot be certain that neither we nor our consumers will be materially impacted by continued pressures. In addition, the global macroeconomic environment has been negatively affected by, among other things, the 2024 presidential election, increased US trade tariffs and trade disputes between the United States, China and other countries, the Houthi attacks on marine vessels in the Red Sea, political tensions between Taiwan and China, political demonstrations, and foreign governmental debt concerns which have caused, and are likely to continue to cause, uncertainty and instability in local economies and in global financial markets. In early 2025, there have been significant changes and proposed changes to US trade policies. Since March 2025, President Trump has announced new tariffs on foreign imported goods from countries worldwide, including additional tariffs on substantially all products imported from China. Some of these tariffs have been paused or reduced, but we cannot predict whether any of these reductions will remain in place or pauses will lapse or be extended, or whether any tariffs will be increased or decreased. These additional tariffs, including pauses, reductions or additional increases, as well as a government’s adoption of “buy national” policies or retaliation by another government against such tariffs or policies, have introduced significant uncertainty into the market and may affect the cost to manufacture

Source: Item 1A, 10-K 0001600033-26-000020 vs Item 1A, 10-K 0001600033-25-000016

MD&A181 words changed in this paragraph; it is 43% similar to last year's version.
On March 3, August 5, 2025, the Company we entered into the Fourth Fifth Amendment to the Amended and Restated Credit Agreement and First Amendment to Pledge and Security Agreement (the “Fourth “Fifth Amendment”). The Fourth Fifth Amendment, among other things, established a revolving credit term loan facility in an aggregate original principal amount of $500 $600.0 million (the “New Revolving “Term Facility”), refinanced made customary changes in connection with adding a term loan facility, increased the existing indebtedness under the Existing Credit Agreement and reduced maximum permitted consolidated total net leverage ratio financial covenant, increased the interest rate margin for loans. Additionally, certain baskets loans under our existing Revolving Credit Facility and increased the Amended unused line fee under our existing Revolving Credit Agreement were increased as part of the Fourth Amendment. Facility. The proceeds of the New Revolving Term Facility are were made available to e.l.f e.l.f. Cosmetics and certain of our other subsidiaries to pay a portion of the Company consideration for working capital, capital expenditures and other general corporate purposes, including to finance acquisitions and investments permitted under the Amended Credit Agreement and other permitted distributions on account of our equity interests of the Company and its subsidiaries. In addition, up to $35 million of the New Revolving Facility is available for issuing letters of credit. rhode Acquisition. The maturity date of the New Revolving Term Facility is March 3, 2030. The unused balance of the New Revolving Credit Facility as of March 31, 2025 was $243.3 million.

Source: Item 7, 10-K 0001600033-26-000020 vs Item 7, 10-K 0001600033-25-000016

Legal Proceedings140 words changed in this paragraph; it is 61% similar to last year's version.
On March 6, 2025 and April 8, 2025, the Company, our its Chief Executive Officer, and our its Chief Financial Officer (collectively, “Defendants”) were named as defendants in separate purported securities class action complaints filed in the United States District Court for the Northern District of California by plaintiffs Luke Rottman and Boston Retirement System. The complaints in both purported securities class actions allege that Defendants made false or misleading statements in violation of Section 10(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 thereunder, and violated Section 20(a) of the Exchange Act, and seek damages and other relief. On May 5, 28, 2025, the court consolidated the two putative shareholders filed motions for lead plaintiff, with one of those motions also seeking to consolidate the purported securities class actions into one action. Those motions remain pending. action suits, and appointed Boston Retirement System and Metropolitan Employee Benefit System as lead plaintiffs. Lead plaintiffs filed an amended consolidated complaint on July 23, 2025. Defendants filed a motion to dismiss the amended consolidated complaint on September 5, 2025. On February 4, 2026, the Court granted defendants’ motion to dismiss as to nearly all of plaintiffs’ challenged statements, but found that plaintiffs adequately stated a claim as to statements made on November 21, 2024. Lead Plaintiffs did not file a second amended complaint, and Defendants filed an answer responding to the consolidated complaint on April 3, 2026. The case is in the early stages of discovery.

Source: Item 3, via Note 9 – Commitments and contingencies, 10-K 0001600033-26-000020 vs Item 3, via Note 9 – Commitments and contingencies, 10-K 0001600033-25-000016

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of ELF's Risk Factors and MD&A, 10-K May 21, 2026 against 10-K May 29, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
In addition, the global macroeconomic environment has been negatively affected by, among other things, the change in administration following the 2024 US presidential election, increased US trade tariffs and trade disputes between the United States, China and other countries, international conflict (such as the war in Iran, the broader conflict in the Middle East and Russia's invasion of Ukraine), the Houthi attacks on marine vessels in the Red Sea, political tensions between Taiwan and China, political demonstrations, and foreign governmental debt concerns which have caused, and are likely to continue to cause, uncertainty and instability in local economies and in global financial markets. For example, we have a retail partner located in certain Middle-Eastern countries. In February 2026, Israel and the United States initiated a coordinated military operation in Iran. In response, Iran launched counter-attacks against Israel and other countries in the region, including Bahrain. During these attacks, our retail partner had to shutter its stores in Bahrain temporarily, thus impacting our retail sales in the region. Additionally, the conflicts in the Middle East have led to higher oil prices and created supply imbalances in the global market for oil and natural gas. The extent and duration of these effects cannot be reliably predicted, and these conflicts may have other adverse effects on the global economy. If these conflicts continue or expand further into other countries, not only could they further adversely affect our sales with our retail partner in Middle-Eastern countries, but they could also lead to increased shipping costs, transportation delays, embargos, and other supply chain concerns, all of which could have a material adverse effect on our business, financial condition, results of operations, and cash flows.
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
To remain competitive, we must continue to enhance and improve the responsiveness, functionality and features of our information technology, including our e-commerce websites and mobile applications. Our competitors are continually
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
President Trump’s December 2025 Executive Order “Ensuring a National Policy Framework for Artificial Intelligence.” This Executive Order establishes a federal policy favoring a uniform national AI regulatory framework designed to promote innovation and U.S. global competitiveness and directs federal agencies to identify, challenge, and potentially pre-empt state and local AI laws that are viewed as inconsistent with or burdensome to this national approach. The White House also released a National Policy Framework for Artificial Intelligence in March 2026 that calls for broad federal preemption of existing state AI laws while taking a “light-touch” regulatory approach using existing agencies. The release of this framework follows the release of a discussion draft of Senator Marsha Blackburn’s TRUMP AMERICA AI Act, which would represent the most comprehensive piece of federal AI legislation proposed in the U.S. It remains to be seen how agencies will effectuate these directives, and how states will approach AI legislation moving forward. Any or all of the foregoing regulatory developments could affect our use of AI and our ability to provide, improve or commercialize our services, require changes to our operations and processes, and materially adversely affect our business, results of operations, and financial condition. Further, any failure or perceived failure by us to comply with existing or newly enacted laws, regulations and other requirements relating to AI technologies could result in legal claims or proceedings (including class actions), regulatory investigations or enforcement actions.
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
fraudulently use consumer information for their own gain or facilitate the fraudulent use of such information. Overall, we may have little recourse if we process a criminally fraudulent transaction.
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
Further, in 2024, the National Security Division of the U.S. Department of Justice (DOJ) issued a new rule—referred to as the “Data Security Program” (DSP)—to implement Executive Order 14117 aimed at preventing access to “bulk U.S. sensitive personal data” and “government-related data” by “countries of concern” (including China, Russia, Iran, North Korea, Cuba, and Venezuela) and “covered persons” (as all such terms are defined in the DSP). Effective as of April 8, 2025, and fully enforceable as of July 9, 2025, the DSP imposes stringent obligations on companies within its scope and prohibits or restricts “covered data transactions” that grant countries of concern or covered persons access to bulk U.S. sensitive personal data or any amount of government-related data. The DSP is new, complex and has yet to be enforced, and as such, there is a risk that our interpretation of its applicability, scope, and requirements is incorrect, incomplete, or misapplied. Compliance with the DSP may require us to invest heavily in data security and compliance measures, such as implementing and complying with the Cybersecurity and Infrastructure Security Agency’s guidelines and other burdensome recordkeeping, reporting, and auditing requirements. It may also require us to implement new processes, stop or restrict certain data transfers, alter the geographic scope of our operations, cease doing business with certain third parties or using certain tools or vendors, or change how data flows throughout our business, any of which could materially impact our business operations or hinder our ability to grow our business. Finally, non-compliance with the DSP could result in significant civil or criminal penalties, which could materially adversely affect our business, results of operations, and financial condition.
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
In addition, the UK General Data Protection Regulation and Data Protection Act 2018 (collectively, the “UK GDPR”) and the EU’s General Data Protection Regulation (the “EU GDPR”) (the EU GDPR and UK GDPR together referred to as the “GDPR”) impose comprehensive data privacy compliance obligations in relation to the collection, processing, sharing, disclosure,
Read it in 10-K May 21, 2026 at sec.gov
AddedRisk Factors
enhance long-term stockholder value or may not prove to be the best use of our cash. Share repurchases could have an impact on our share trading prices, increase the volatility of the price of our common stock, or reduce our available cash balance such that we will be required to seek financing to support our operations.
Read it in 10-K May 21, 2026 at sec.gov
Show the other 44
RemovedRisk Factors
Any inquiry into the regulatory status of our cosmetics and any related interruption in the marketing and sale of these products could damage our reputation and image in the marketplace.
Read it in 10-K May 29, 2025 at sec.gov
RewordedRisk Factors
For example, US and global markets have been experiencing experienced volatility and disruption due to interest rate and inflation increases, such as higher inflation rates in the United States, which increased in the second half of 2021 and have remained above the Federal Reserve’s inflation target, as well as the continued escalation of geopolitical tensions, tensions and conflict, including those as a result of resulting from the conflicts between Russia and Ukraine and war in Iran, the broader conflict in the Middle East. East and Russia's invasion of Ukraine.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
Trade restrictions implemented by the United States, China, Canada, the UK, United Kingdom (the “UK”), the European Union (the “EU”) or any of the other jurisdictions in which we conduct significant business in connection with a global trade war could result in us raising may affect our suppliers’ ability to source products efficiently or create other supply chain disruptions, impacting the prices further or making changes to of and supply of our operations, any of which could result in a material adverse effect on our financial condition and results of operations. products.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
As a company engaged in distribution on a global scale, our operations, including those of our third-party manufacturers, suppliers, brokers and delivery service providers, are subject to the risks inherent in such activities, including industrial accidents, environmental events, strikes and other labor disputes (such as the recent port strike), strikes in 2024), disruptions or delays in shipments, shipments (including delays at international and domestic ports), disruptions in information systems, product quality control, safety, licensing requirements and other regulatory issues, costs (including customs duties, quotas and tariffs), as well as weather events and natural disasters (such as the January 2025 Southern California wildfires and the 2024 Atlantic hurricanes), disasters, pandemics (such as the coronavirus pandemic), border disputes, international conflict (such as the ongoing military war in Iran, the broader conflict in Ukraine and the Middle East), East and Russia's invasion of Ukraine), acts of terrorism and other external factors over which we and our third-party manufacturers, suppliers, brokers and delivery service providers have no control.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
The potential effects of these laws states’ legislation are potentially significant far-reaching and may require us to modify our data collection or processing practices and policies and to incur substantial costs and expenses in an effort to comply, and increase our potential exposure it is unclear whether, and if so how, the US Congress will respond to regulatory enforcement and/or litigation. these overlapping, state-by-state enactments.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
Nonetheless, as As a result of the additional US tariffs announced since early 2025 as well as inflation, on August 1, 2025, the Company will raise we raised prices globally for all products sold, which could result in the loss of consumers and materially and adversely affect our business, financial condition and results of operations. sold.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
In addition, all the shares of common stock subject to stock options and restricted stock units and shares of restricted stock awards outstanding and reserved under our 2014 Equity Incentive Plan, our 2016 Equity Incentive Award Plan and our 2016 Employee Stock Purchase Plan have been registered on Form S-8 under the Securities Act and such shares, once the underlying equity award vests, will be eligible for sale in the public markets, subject to Rule 144 limitations applicable to affiliates.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
The substantial up-front investment required, the lack of consumer awareness of our products in jurisdictions outside of the United States, differences in consumer preferences and trends between the United States and other jurisdictions, the risk of inadequate intellectual property protections and differences in packaging, labeling and related laws, rules and regulations are all substantial matters that need to be evaluated prior to doing business in new territories.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
While the majority of the substantive requirements will only not apply two years later, until the second half of 2026 (subject to proposed amendments to delay their implementation under the EU Digital Omnibus on AI Regulation Proposal), certain of its the EU AI Act’s provisions regarding prohibited AI systems and AI literacy obligations are already applicable.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
For example, in In connection with our acquisition of Naturium, rhode, we paid total cash consideration of approximately $333 $590.1 million using the proceeds from an incremental term loan under our existing credit facility, borrowings on our existing revolving facility, and cash on the balance sheet and sheet, as well as approximately $58 $300.3 million of our stock. stock, and a potential earnout initially valued at $7.1 million.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
In addition, if we are found to infringe, misappropriate, dilute or otherwise violate third-party trademark, patent, copyright or other proprietary rights, our ability to use brands to the fullest extent we plan may be limited, we may need to obtain a license, which may not be available on commercially reasonable terms, or at all, or we may need to redesign or rebrand our marketing strategies or products, which may be expensive or may not be possible.
Read it in 10-K May 21, 2026 at sec.gov
RewordedRisk Factors
We cannot predict whether these policies will continue or if new policies will be enacted; however, we uncertainty regarding these policy changes in trade regulation or additional incremental tariffs or counter-tariffs could experience have a material adverse effect on our business, financial condition and results of operations if these or other incremental tariffs go into effect. operations.
Read it in 10-K May 21, 2026 at sec.gov
Quiet changesRisk Factors
We have made certain assumptions relating to our potential acquisition of rhode that may prove to be inaccurate, including as the result of the failure to realize the expected benefits of the acquisition, failure to realize expected revenue growth rates and higher than expected operating, transaction and integration costs, as well as general economic and business conditions that adversely affect rhode.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
Unless otherwise stated, the following discussion and analysis are for the fiscal year ended March 31, 2026, compared to the fiscal year ended March 31, 2025. Discussion and analysis for the fiscal year ended March 31, 2025 compared to the year ended March 31, 2024 may be found in the section titled “Management’s discussion and analysis of financial condition and results of operations” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, filed with the SEC on May 29, 2025.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
On July 31, 2025, the US administration issued a formal Executive Order modifying the reciprocal tariff regime under the IEEPA. However, in February 2026, the Supreme Court of the United States ruled that the IEEPA does not authorize the US administration to impose tariffs, and the tariffs paid by importers under the Executive Order are subject to refund. We are evaluating the impact of the Supreme Court ruling and the subsequent order issued by the CIT, and are monitoring related developments from the CBP regarding its plan to process refunds to importers of record, including the launch on April 20, 2026 of the CBP's Consolidated Administration and Processing of Entries (“CAPE”) system for submitting refund claims, as well as the administration’s decision on whether or not to appeal the CIT’s order. Effective February 24, 2026, the US administration has imposed a 10% global tariff under Section 122 of the Trade Act of 1974 that could remain in place for up to 150 days, and may, by legislative action, be extended. Multiple legal challenges to the Section 122 tariffs have been filed, and on May 7, 2026, the U.S. Court of International Trade ruled that the Section 122 tariffs are unlawful; however, the court's injunction applies only to the named plaintiffs, and the tariffs remain in effect for all other importers pending appeal. During the fiscal year 2026, the Company paid approximately $58.5 million of IEEPA Tariffs. These tariffs, as well as a government’s adoption of “buy national” and similar policies or retaliation by another government against such tariffs or policies, could introduce significant uncertainty into the market and may affect the prices of and supply of the products available to us. Tariffs also can impact our or our suppliers’ ability to source products efficiently or create other supply chain disruptions. We may not be able to fully or substantially mitigate the impact of these or future tariffs, pass price increases on to our customers or secure adequate alternative sources of products or materials for our products, which would have a material adverse effect on our business, financial condition and results of operations.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
On August 5, 2025, we consummated the acquisition (the “rhode Acquisition”) of HRBeauty LLC (“rhode”), the fast-growing, multi-category lifestyle beauty brand founded by Hailey Bieber for a purchase price of $897.5 million in a combination of cash, shares of our common stock, and potential earnout. See Note 3, “Acquisitions,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for further details.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
In connection with the rhode Acquisition, we recorded a liability at fair value for the contingent consideration potentially payable to the sellers of rhode subject to achievement of certain earnout thresholds, with a maximum payment of $200.0 million. We expect to pay (if due and owing) annually within four months after each measurement period ending September 30, 2026, 2027, and 2028. The fair value of the liability is calculated using Monte Carlo simulation based on corresponding projected revenue. We evaluate the fair value of the contingent consideration each reporting period and adjust the carrying value as new information becomes available. See Note 3, “Acquisitions,” and Note 7, “Fair value of financial instruments,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
In connection with the rhode Acquisition, the Company recorded a fair value adjustment of $57.6 million for the fiscal year ended March 31, 2026, driven by the outperformance of rhode's revenue results relative to the earnout thresholds set forth in the merger agreement entered into in connection with the rhode Acquisition.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
On August 5, 2025, we entered into the Fifth Amendment. The Fifth Amendment, among other things, established the Term Facility, made customary changes in connection with adding a term loan facility, increased the maximum permitted consolidated total net leverage ratio financial covenant, increased the interest rate margin for loans under our existing Revolving Credit Facility and increased the unused line fee under our existing Revolving Credit Facility. The proceeds of the Term Facility were made available to e.l.f. Cosmetics and certain of our other subsidiaries to pay a portion of the consideration for the rhode Acquisition. The maturity date of the Term Facility is March 3, 2030.
Read it in 10-K May 21, 2026 at sec.gov
AddedMD&A
In connection with the rhode Acquisition, we recorded a liability at fair value for the contingent consideration potentially payable to the sellers of rhode subject to achievement of certain earnout thresholds, with a maximum payment of $200.0 million. We expect to pay (if due and owing) annually within four months after each measurement period ending September 30, 2026, 2027, and 2028. The fair value of the liability is estimated using discounted future cash flows based on a Monte Carlo simulation methodology using significant level 3 inputs such as forecasts of revenue. We evaluate the fair value of the contingent consideration each reporting period and adjust the carrying value as new information becomes available. See Note 3, “Acquisitions,” and Note 7, “Fair value of financial instruments,” in the Notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
Read it in 10-K May 21, 2026 at sec.gov
RemovedMD&A
The US tariff policies are continuing to evolve. As a result, our risks and mitigation plans will also continue to evolve as further developments arise. Any alteration of trade agreements and terms between China and the United States, including limiting trade with China, imposing additional tariffs on imports from China and potentially imposing other restrictions on imports from China to the United States may result in further or higher tariffs or retaliatory trade measures by China. We are in the process of determining our incremental tariff cost exposure in light of continuing changes to tariff policies, and the full extent of our potential mitigation plans, as well as the associated timing to implement such plans. To mitigate our risk of ongoing exposure to tariffs, the Company will raise prices globally for all products sold. The Company may also seek to shift production outside of China into regions where we expect tariffs to be lower and to source the same products in more than one region, to the extent it is possible and not cost-prohibitive.
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
On May 28, 2025, the Company entered into a definitive agreement to acquire rhode, a fast-growing, multi-category lifestyle beauty brand founded by Hailey Bieber and known for its collection of high-performance, skin-focused products. The deal is comprised of $800.0 million at closing, subject to customary adjustments, in a combination of $600.0 million of cash and $200.0 million of stock, and potential earnout consideration of up to $200.0 million based on the future growth of the brand over a three-year timeframe. The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close in the second quarter of Fiscal 2026. The transaction will be accounted for as a business combination using the acquisition method of accounting, which requires certain assets acquired and liabilities assumed to be recognized at fair
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
value as of the acquisition date. As of the date of this filing, the Company is currently evaluating the preliminary allocation of the purchase price to the net assets acquired and liabilities that will be assumed in the transaction.
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
We recorded an impairment charge on one of our investments of $2.9 million during the fiscal year ended March 31, 2024, as an identified event or change in circumstances resulted in an indicator of impairment. We did not record an impairment charge on our investment during the fiscal year ended March 31, 2025 as any identified events or changes in circumstances did not result in an indicator of impairment during that period.
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
Impairment of equity investment was $2.9 million in the fiscal year ended March 31, 2024. We elected the measurement alternative for equity investments that do not have readily determinable fair values. We recorded an impairment charge on one of our investments of $2.9 million during the fiscal year ended March 31, 2024, as an identified event or change in circumstances resulted in an indicator of impairment. We did not record an impairment charge on our investment during the fiscal year ended March 31, 2023 as any identified events or changes in circumstances did not result in an indicator of impairment during that period.
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
All amounts under the Amended Revolving Credit Facility are available for draw until the maturity date on April 30, 2026. The Amended Revolving Credit Facility was collateralized by substantially all of the Company’s assets and requires payment of an unused fee ranging from 0.10% to 0.30% (based on Company’s consolidated total net leverage ratio (as defined in the Amended Credit Agreement)) times the average daily amount of unutilized commitments under the Amended Revolving Credit Facility. The Amended Revolving Credit Facility also provided for sub-facilities in the form of a $7 million letter of credit and a $5 million swing line loan.
Read it in 10-K May 29, 2025 at sec.gov
RemovedMD&A
Prior to the Second Amendment (as defined below), both the Amended Revolving Credit Facility and the Amended Term Loan Facility bore interest, at the borrowers’ option, at either (i) a rate per annum equal to an adjusted LIBOR rate determined by reference to the cost of funds for the United States (“US”) dollar deposits for the applicable interest period (subject to a minimum floor of 0%) plus an applicable margin ranging from 1.25% to 2.125% based on our consolidated total net leverage ratio (the “Applicable Margin”) or (ii) a floating base rate plus an applicable margin ranging from 0.25% to 1.125% based on our consolidated total net leverage ratio. On March 29, 2023, the Company amended the Amended Credit Agreement to transition the benchmark from LIBOR to an adjusted Secured Overnight Financing Rate (“SOFR”) (which is equal to the applicable SOFR plus 0.10%) (such transaction, the “First Amendment”). In connection with the First Amendment, all outstanding LIBOR loans were converted to SOFR loans. The annual interest rate for SOFR borrowings will be equal to term SOFR plus 0.10% subject to a floor of 0%, plus a margin ranging from 1.25% to 2.125%.
Read it in 10-K May 29, 2025 at sec.gov
RewordedMD&A
SOFR (subject to a 0.00% floor) or an alternate base rate (subject to a 1.00% floor) as set forth in the Fourth Fifth Amendment, plus an interest rate margin, to be determined based on consolidated total net leverage ratio levels, ranging from, (i) in the case of SOFR loans, 1.125% 1.50% to 1.875%; provided that if SOFR is less than 0.00%, such rate shall be deemed to be 0.00%, 2.25%, and (ii) in the case of alternate base rate loans, 0.125% 0.50% to 0.875%; provided that if the alternate base rate is less than 1.00%, such rate shall be deemed to be 1.00%. 1.25%.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
The increase in net working capital was primarily driven by a $2.7 million increase in accounts receivable, a $75.9 $67.4 million increase in prepaid and other assets, assets and $17.5 million increase in accounts receivable, partially offset by a $7.9 $75.3 million decrease in other liabilities, and a $23.4 million decrease increase of accounts payable and accrued expenses, partially offset by expenses and a $4.9 $7.3 million decrease in inventory inventory.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
The increase on a dollar basis was primarily related to increased marketing marketing, merchandising and digital spend distribution costs of $130.0 $129.1 million, increased compensation and benefits expense of $32.9 million, increased operations costs of $26.4 million, increased retail fixturing and visual merchandising costs of $21.1 $55.1 million, increased depreciation and amortization of $12.2 million and $35.0 million, increased professional fees of $11.5 $20.6 million, and increased regulatory fees of $8.6 million.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
The Company We used the Incremental Term Loan Loan, together with cash from its our balance sheet and additional borrowings under our Amended Revolving Credit Facility Facility, to consummate the Acquisition acquisition of Naturium (as defined in Note 3 hereto) 3, “Acquisitions,” in the Notes to our unaudited condensed consolidated financial statements included elsewhere in this Annual Report on Form 10-K) and to pay related fees and expenses in connection with the Acquisition acquisition of Naturium and Second Amendment.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
This For the fiscal year ended March 31, 2026, net cash provided by financing activities was offset $533.9 million and was primarily driven by proceeds from long term debt of $256.7 $600.0 million, proceeds from the revolving line of credit of $50.0 million and cash received from the exercise of stock options of $1.0 $5.8 million.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
“Exhibits, While our significant accounting policies are more fully described in Note 2, “Summary of significant accounting policies,” in the Notes to our consolidated financial statement schedules,” statements included elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies and estimates are critical to our business operations and understanding of our financial results.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
See the risk factor titled “Additional “Changes in the US tariffs or other and international trade policies, including tariffs, trade restrictions placed on imports, and retaliatory trade measures taken by other countries and resulting trade wars may have a material adverse impact on the Company’s financial condition and results of operations” included as part of Item 1A. our business,
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
Interest expense increased $6.8 $21.5 million, or 97%, to $35.3 million in the fiscal year ended March 31, 2026, as compared to $13.8 million in the fiscal year ended March 31, 2025, as compared to $7.0 million in the fiscal year ended March 31, 2024. 2025.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
Fiscal year ended March 31, (percentage of net sales) 2026 2025 2024 2023 Net sales 100% 100% 100% Cost of sales 29% 29% 33% 29% Gross profit 71% 71% 67% 71% Selling, general and administrative expenses 63% 59% 56% 56% Change in fair value of contingent consideration 4% —% —% Operating income 4% 12% 15% 12% Other income (expense), income, net —% —% —% Impairment of equity investment —% —% —% Interest expense, net (2)% (1)% (1)% —% Loss on extinguishment of debt —% —% —% Income before provision for income taxes 2% 11% 14% 11% Income tax provision (1)% (3)% (1)% —% Net income 2% 9% 12% 11%
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
The change in the income tax provision was primarily driven by an increase a decrease in income before the provision for income taxes of $76.9 million, partially offset by an increase in discrete tax benefits of $14.4 million, primarily related to stock-based compensation. $105.0 million.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
Gross profit increased $211.6 $221.7 million, or 29%, 24%, to $1,157.3 million in the fiscal year ended March 31, 2026, compared to $935.7 million in the fiscal year ended March 31, 2025, compared to $724.1 million in the fiscal year ended March 31, 2024. 2025.
Read it in 10-K May 21, 2026 at sec.gov
RewordedMD&A
For the fiscal year ended March 31, 2025, net cash used in financing activities This was $74.4 million and was primarily driven offset by the repayment of previous Revolving Credit line of $89.5 $50.0 million, repurchases of our common stock of $67.1 $50.0 million, repayments on the Amended Term Loan Facility of $173.4 $15.0 million and payment of debt issuance costs of $2.1 $6.9 million associated with the new Revolving Credit Facility.
Read it in 10-K May 21, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ELF/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.